<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7438404\results\search\country\results.xml">
  <result pre="UberlÃ¢ndiaUberlÃ¢ndiaBrazil Edited by: Anna Kramvis, University of the Witwatersrand, Johannesburg," exact="South Africa" post="Reviewed by: Olivier Terrier, UMR 5308 Centre International de"/>
  <result pre="(CIRI), France; Maryam Dadar, Razi Vaccine and Serum Research Institute," exact="Iran" post="*Correspondence: Ana Carolina Gomes Jardim, jardim@ufu.br This article was"/>
  <result pre="in clinical phase 3, being tested in several countries, including" exact="the United States," post="Brazil, and countries in Asia and Africa; (ii) mRNA-1273"/>
  <result pre="clinical phase 3, being tested in several countries, including the" exact="United States," post="Brazil, and countries in Asia and Africa; (ii) mRNA-1273"/>
  <result pre="been assessed by several clinical trials in different countries like" exact="France" post="(NCT04365725), Canada (NCT04330690), and the United States (NCT04292899), which"/>
  <result pre="by several clinical trials in different countries like France (NCT04365725)," exact="Canada" post="(NCT04330690), and the United States (NCT04292899), which have been"/>
  <result pre="trials in different countries like France (NCT04365725), Canada (NCT04330690), and" exact="the United States" post="(NCT04292899), which have been conducted based on the first"/>
  <result pre="in different countries like France (NCT04365725), Canada (NCT04330690), and the" exact="United States" post="(NCT04292899), which have been conducted based on the first"/>
  <result pre="the first reported treatment of COVID-19 with Remdesivir in Washington," exact="United States" post="(Holshue et al., 2020). In the first findings from"/>
  <result pre="Clinical trials have been conducted in different medical centers in" exact="Argentina" post="(NCT04381884), Mexico (NCT04391127), Spain (NCT04390022), and the United States"/>
  <result pre="have been conducted in different medical centers in Argentina (NCT04381884)," exact="Mexico" post="(NCT04391127), Spain (NCT04390022), and the United States (NCT04374279) to"/>
  <result pre="conducted in different medical centers in Argentina (NCT04381884), Mexico (NCT04391127)," exact="Spain" post="(NCT04390022), and the United States (NCT04374279) to assess the"/>
  <result pre="medical centers in Argentina (NCT04381884), Mexico (NCT04391127), Spain (NCT04390022), and" exact="the United States" post="(NCT04374279) to assess the clinical implications of the use"/>
  <result pre="centers in Argentina (NCT04381884), Mexico (NCT04391127), Spain (NCT04390022), and the" exact="United States" post="(NCT04374279) to assess the clinical implications of the use"/>
  <result pre="al., 2020a). Tocilizumab is an IL-6 receptor antagonist approved by" exact="the US" post="FDA for the treatment of severe CRS (Grupp et"/>
  <result pre="Additionally, Toniati and collaborators administered Tocilizumab in 100 patients in" exact="Italy" post="(average age of 62 years old) who had been"/>
  <result pre="the performance of chloroquine in vitro, clinical studies conducted in" exact="China" post="and France showed contradictory clinical data (Chen J. et"/>
  <result pre="of chloroquine in vitro, clinical studies conducted in China and" exact="France" post="showed contradictory clinical data (Chen J. et al., 2020;"/>
  <result pre="treatment of patients with SARS during the SARS-CoV outbreak in" exact="Hong Kong" post="in the early 2000s (Cheng et al., 2005). It"/>
 </snippets>
</snippetsTree>
